The Quiet Consolidation Happening in Outpatient Surgery
Ambulatory surgery centers built their reputations on being the lean, independent alternative to hospital-owned facilities – lower overhead, faster scheduling, and physicians who actually run the place. For decades, that independence was the selling point. Now, a growing number of regional ASCs are trading that autonomy for a check from United Surgical Partners International, the nation’s largest ASC operator, and doing it quietly enough that most patients never notice the change at all.
USPI, a subsidiary of Tenet Healthcare, already operates more than 400 surgical facilities across the country. The pace of its regional acquisitions has accelerated noticeably over the past two years, with smaller, physician-owned centers in mid-sized markets becoming the clearest targets. These are not distressed sales. Many of the centers being acquired are profitable, well-staffed, and fully booked. The sellers are choosing this exit for reasons that go beyond financial pressure – and that distinction matters.
Why Profitable Centers Are Still Selling
The calculus for an ASC owner considering a sale to USPI is not simply about being in trouble. Regulatory complexity has increased substantially. Payer contract negotiations have grown more adversarial. Recruiting anesthesiologists and specialty surgeons into independent settings has become harder as larger systems offer signing bonuses and employment stability that private centers cannot easily match. The administrative burden alone – credentialing, billing compliance, quality reporting – can consume physician attention that should be going toward patient care.
USPI’s pitch to these owners typically includes a partial equity buyout combined with a continued ownership stake in the acquired center. Physicians do not simply cash out and walk away. They retain skin in the game, which keeps the clinical operation running smoothly while USPI absorbs the administrative and contracting infrastructure. For a surgeon-owner in their late 50s who does not want to hand the business to an associate or spend years grooming a successor, this structure solves a real succession problem without requiring a full exit.
The payer angle is also not a minor detail. Independent ASCs negotiate contracts facility by facility, which puts them at a disadvantage against major insurers. USPI negotiates across its entire network, which means an acquired center can immediately benefit from higher reimbursement rates than it could have achieved independently. That lift in contracted rates can be substantial – enough that the center’s post-acquisition revenue per case improves even after USPI takes its management fees and overhead cut.
What Regional Markets Are Seeing
The pattern is most visible in Sun Belt states, the Mountain West, and mid-sized Midwestern cities – markets where population growth has driven outpatient procedure volume up, but where independent physician groups have not consolidated into large enough networks to negotiate from strength. A single orthopedic surgery center in a city of 300,000 people is attractive to USPI precisely because it has market presence without market power.
Hospital systems in these same markets have watched this consolidation with concern. Many had hoped to acquire or affiliate with local ASCs themselves, viewing outpatient surgical volume as something they needed to own rather than lose. USPI moves faster in many cases – less institutional approval process, a standardized deal structure, and a clear value proposition for physician-owners who are skeptical of hospital employment models.
The Tradeoffs That Don’t Show Up in the Deal Memo
Acquired centers typically retain their branding and local identity for some period after closing. The name on the door stays the same. The surgeon performing the procedure is the same person who operated the center independently for fifteen years. From a patient’s perspective, very little appears to change. The operational integration happens in back-office systems, payer contracts, supply chain purchasing, and staffing protocols – none of which are visible at the point of care.
Over time, though, the operational homogenization does affect how centers function. USPI has preferred vendors for surgical supplies, standardized protocols for scheduling and case mix, and performance benchmarks that centers are expected to meet. A center that previously scheduled cases based entirely on surgeon preference may find that model adjusted to optimize facility utilization. These are not necessarily bad changes – many of them reduce waste and improve throughput – but they represent a real reduction in the day-to-day autonomy that physician-owners originally valued.
The consolidation of regional gastroenterology practices into private equity rollups has followed a similar arc, where early-stage acquisitions preserve local identity while standardization deepens gradually over a three-to-five year integration window. ASC consolidation under USPI is moving along the same timeline, and physician-owners who expected to maintain meaningful operational control often find that control narrowing as USPI’s systems embed more deeply into daily operations.
The more interesting tension is what happens to the centers that don’t sell. Independent ASCs that remain outside the USPI network face payer contracts that are increasingly benchmarked against what USPI secures for its affiliated centers. If USPI drives reimbursement rates up across a regional market, independent centers may benefit indirectly – or they may find that payers draw a harder line with facilities that lack the volume leverage of a national operator. The independent holdouts are essentially betting that clinical reputation and physician loyalty are durable competitive advantages in a market that is quietly being repriced around them.
